Every cognitive ingredient has "studies" behind it — but studies vary enormously in quality, and marketing rarely distinguishes a large human trial from a promising result in a petri dish. Here is the plain-English framework we use to grade evidence, so you can apply the same skepticism to any product.

Four questions to ask about any ingredient

  • Is there human evidence, or only lab and animal data? Animal and test-tube results are hypotheses, not proof of a human benefit.
  • Was the studied dose realistic, and does the product match it? A real effect at 300 mg says nothing about a 30 mg sprinkle.
  • Is the effect acute (same day) or cumulative (weeks of daily use)? Both can be valid, but they are different promises.
  • How large and consistent is the effect? Small, mixed, or single-study results deserve caution, not confidence.

The four grades we use

  • Grade A — strong: multiple human trials with consistent effects.
  • Grade B — moderate: several human trials, with some mixed results.
  • Grade C — limited: early or small human trials.
  • Emerging — mostly preclinical or preliminary human data.

Why almost nothing earns an A

In the stimulant-free cognitive space, honest grading tops out at B for most ingredients. Genuinely strong, consistent, multi-trial human evidence for a same-day cognitive lift is rare outside of stimulants like caffeine. When a brand grades everything it sells as "clinically proven" or implies an A across the board, that is usually grade inflation — and it quietly undermines the few claims that are actually well supported.

Applying it in practice

L-theanine and Bacopa monnieri, for example, sit at a defensible B — several human trials, modest and specific effects. Lion's Mane, by contrast, is honestly Emerging: interesting early work, but a thin human evidence base. Neither framing is an attack or an endorsement; it is just calibrating your expectations to what the research actually supports. That calibration — not hype in either direction — is the whole point.

References

This article draws on the primary human research below; see the linked studies for full methods and doses.

  • Calabrese C, Gregory WL, Leo M, et al. "Effects of a standardized Bacopa monnieri extract on cognitive performance, anxiety, and depression in the elderly." Journal of Alternative and Complementary Medicine, 2008;14(6):707–713. PMID: 18611150.
  • Laws KR, Sweetnam H, Kondel TK. "Is Ginkgo biloba a cognitive enhancer in healthy individuals? A meta-analysis." Human Psychopharmacology, 2012;27(6):527–533. PMID: 23001963.